CL2014000020A1 - Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende. - Google Patents
Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende.Info
- Publication number
- CL2014000020A1 CL2014000020A1 CL2014000020A CL2014000020A CL2014000020A1 CL 2014000020 A1 CL2014000020 A1 CL 2014000020A1 CL 2014000020 A CL2014000020 A CL 2014000020A CL 2014000020 A CL2014000020 A CL 2014000020A CL 2014000020 A1 CL2014000020 A1 CL 2014000020A1
- Authority
- CL
- Chile
- Prior art keywords
- viral cough
- cough
- understands
- formula
- pharmaceutical composition
- Prior art date
Links
- 206010011224 Cough Diseases 0.000 title 3
- 230000003612 virological effect Effects 0.000 title 2
- 230000001154 acute effect Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161505075P | 2011-07-06 | 2011-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014000020A1 true CL2014000020A1 (es) | 2014-08-01 |
Family
ID=47437403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014000020A CL2014000020A1 (es) | 2011-07-06 | 2014-01-06 | Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20140121213A1 (es) |
| EP (1) | EP2729149A4 (es) |
| JP (1) | JP2014518281A (es) |
| KR (1) | KR20140059774A (es) |
| CN (1) | CN103764148A (es) |
| AR (1) | AR087053A1 (es) |
| AU (1) | AU2012279091A1 (es) |
| BR (1) | BR112014000259A2 (es) |
| CA (1) | CA2840394A1 (es) |
| CL (1) | CL2014000020A1 (es) |
| CO (1) | CO6821963A2 (es) |
| CR (1) | CR20140002A (es) |
| DO (1) | DOP2014000001A (es) |
| EA (1) | EA201490210A1 (es) |
| MA (1) | MA35336B1 (es) |
| MX (1) | MX2014000112A (es) |
| PE (1) | PE20141385A1 (es) |
| PH (1) | PH12014500006A1 (es) |
| TW (1) | TW201302707A (es) |
| WO (1) | WO2013006596A1 (es) |
| ZA (1) | ZA201309533B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9346798B2 (en) | 2012-02-13 | 2016-05-24 | Amgen Inc. | Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors |
| US9051311B2 (en) | 2012-03-09 | 2015-06-09 | Amgen Inc. | Sulfamide sodium channel inhibitors |
| BR112015022385A2 (pt) * | 2013-03-14 | 2017-07-18 | Daiichi Sankyo Co Ltd | droga para uma doença respiratória |
| US10668067B2 (en) | 2016-07-20 | 2020-06-02 | Amgen Inc. | Pyridine sulfonamides |
| WO2020120673A1 (en) | 2018-12-13 | 2020-06-18 | Intervet International B.V. | Process for preparing 1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]p yrazole-4-carboxamide |
| CN109796402A (zh) * | 2018-12-28 | 2019-05-24 | 京博农化科技有限公司 | 一种烟嘧磺隆中间体2-氯-n,n-二甲基烟酰胺的制备方法 |
| EP4405347A1 (en) | 2021-09-24 | 2024-07-31 | Xenon Pharmaceuticals Inc. | Pyridine derivatives and their use as sodium channel activators |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008147864A2 (en) * | 2007-05-22 | 2008-12-04 | Xenon Pharmaceuticals Inc. | Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| TW201139406A (en) * | 2010-01-14 | 2011-11-16 | Glaxo Group Ltd | Voltage-gated sodium channel blockers |
-
2012
- 2012-07-03 JP JP2014519247A patent/JP2014518281A/ja active Pending
- 2012-07-03 AU AU2012279091A patent/AU2012279091A1/en not_active Abandoned
- 2012-07-03 EP EP12806889.7A patent/EP2729149A4/en not_active Withdrawn
- 2012-07-03 CA CA2840394A patent/CA2840394A1/en not_active Abandoned
- 2012-07-03 PH PH1/2014/500006A patent/PH12014500006A1/en unknown
- 2012-07-03 PE PE2014000011A patent/PE20141385A1/es not_active Application Discontinuation
- 2012-07-03 US US14/128,704 patent/US20140121213A1/en not_active Abandoned
- 2012-07-03 MX MX2014000112A patent/MX2014000112A/es unknown
- 2012-07-03 WO PCT/US2012/045350 patent/WO2013006596A1/en not_active Ceased
- 2012-07-03 CN CN201280041598.8A patent/CN103764148A/zh active Pending
- 2012-07-03 BR BR112014000259A patent/BR112014000259A2/pt not_active IP Right Cessation
- 2012-07-03 KR KR1020147002808A patent/KR20140059774A/ko not_active Withdrawn
- 2012-07-03 EA EA201490210A patent/EA201490210A1/ru unknown
- 2012-07-04 AR ARP120102419A patent/AR087053A1/es unknown
- 2012-07-04 TW TW101124063A patent/TW201302707A/zh unknown
-
2013
- 2013-12-17 CO CO13294535A patent/CO6821963A2/es not_active Application Discontinuation
- 2013-12-18 ZA ZA2013/09533A patent/ZA201309533B/en unknown
-
2014
- 2014-01-02 DO DO2014000001A patent/DOP2014000001A/es unknown
- 2014-01-06 CL CL2014000020A patent/CL2014000020A1/es unknown
- 2014-01-06 CR CR20140002A patent/CR20140002A/es unknown
- 2014-02-05 MA MA36731A patent/MA35336B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012279091A1 (en) | 2014-01-16 |
| ZA201309533B (en) | 2014-08-27 |
| EP2729149A1 (en) | 2014-05-14 |
| EP2729149A4 (en) | 2015-01-07 |
| KR20140059774A (ko) | 2014-05-16 |
| CO6821963A2 (es) | 2013-12-31 |
| CR20140002A (es) | 2014-03-05 |
| MA35336B1 (fr) | 2014-08-01 |
| WO2013006596A1 (en) | 2013-01-10 |
| EA201490210A1 (ru) | 2014-05-30 |
| MX2014000112A (es) | 2014-01-31 |
| AR087053A1 (es) | 2014-02-12 |
| CN103764148A (zh) | 2014-04-30 |
| CA2840394A1 (en) | 2013-01-10 |
| US20140121213A1 (en) | 2014-05-01 |
| JP2014518281A (ja) | 2014-07-28 |
| TW201302707A (zh) | 2013-01-16 |
| BR112014000259A2 (pt) | 2017-02-14 |
| DOP2014000001A (es) | 2014-04-30 |
| PE20141385A1 (es) | 2014-10-29 |
| PH12014500006A1 (en) | 2014-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190074T1 (hr) | Aril-ili heteroaril-supstituirani spojevi benzena | |
| DK3366293T3 (da) | Dihydronaphthyridiner og relaterede forbindelser, der er nyttige som kinashæmmere til behandling af proliferative sygdomme | |
| DK4190786T3 (da) | Forbindelser, der er nyttige som hæmmere af atr-kinase | |
| CL2014003035A1 (es) | Compuestos derivados de diazabiciclooctano, inhibidores de beta-lactamasa; composicion farmaceutica que los comprende; proceso para prepararlos; y metodo para tratar una infeccion bacteriana. | |
| BR112015001596A2 (pt) | composição para o tratamento de hiperlipidemia que compreende oxintomodulina. | |
| DK2791134T3 (da) | Kemisk forbindelse, der er anvendelig som mellemprodukt til fremstilling af en catechol-o-methyltransferasehæmmer | |
| CL2014000020A1 (es) | Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende. | |
| BR112014010197A2 (pt) | composto, composição farmacêutica, método de tratamento de um distúrbio | |
| CL2014000814A1 (es) | Compuestos derivados de piridazinona; composicion herbicida que los comprende; y metodo para controlar malezas. | |
| CO7160104A2 (es) | Inhibidores de virus de hepatitis c | |
| DK3330257T3 (da) | Pyrimidinderivater til behandling af virusinfektioner | |
| BR112014003587A8 (pt) | Derivados de 5-flúor-4-imino-3-(substituído)-3,4-dihidropirimidin-2(1h)ona, composição e método para controle ou prevenção de um patógeno fúngico | |
| DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
| CL2014002640A1 (es) | Compuestos pirrolidin, piperidin o azepan sustituidos, inhibidores de met-ap2; procedimiento para prepararlos; y medicamento que los contiene. | |
| BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
| BR112014000033A2 (pt) | compostos para o tratamento de dependência química | |
| DK2678329T3 (da) | Triazolopyridinforbindelser som pim-kinase-hæmmere | |
| CO6940429A2 (es) | Compuestos heterocíclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparación | |
| CR20140263A (es) | Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(-4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo | |
| BR112015007159A2 (pt) | compostos heterocíclicos que contêm azoto para o controle de doenças de plantas | |
| EP2759543A4 (en) | CHROMENIC COMPOUND AND HARDENABLE COMPOSITION | |
| BR112014006420A2 (pt) | compostos, composição farmacêutica, uso de um composto e mètodo para o tratamento ou profilaxia | |
| CO6960548A2 (es) | Polimorfos de arry-380, un inhibidor selectivo de herb2 y composiciones farmacéuticas que los contienen | |
| BR112015003101A2 (pt) | processo para a preparação de um composto. | |
| BR112014028622A2 (pt) | composições de ativador de glucoquinase para o tratamento de diabetes |